Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Burke

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Current Opinion in Drug Discovery & Development|October 29, 2003
Targeting I kappa B kinase for the treatment of inflammatory and other disordersJames R Burke
Biochemical and Biophysical Research Communications|June 11, 2002
The catalytic subunits of IkappaB kinase, IKK-1 and IKK-2, contain non-equivalent active sites when expressed as homodimersJames R Burke, Joann Strnad
Trends in Pharmacological Sciences|February 9, 2007
IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challengesJoann Strnad, James R Burke
The Journal of Organic Chemistry|January 26, 1996
Correlation of Electronic Effects in N-Alkylnicotinamides with NMR Chemical Shifts and Hydride Transfer ReactivityJames R. Burke, Perry A. Frey
Archives of Physical Medicine and Rehabilitation|January 6, 2012
Sound induced vertigo: superior canal dehiscence resulting from blast exposureAdam Mehlenbacher, Bruce Capehart, Dale Bass, et al.
Methods in Enzymology|October 19, 2006
Phage display screening for peptides that inhibit polyglutamine aggregationDaniel J Kenan, Warren J Strittmatter, James R Burke
Archives of Biochemistry and Biophysics|January 29, 2002
Cytosolic phospholipase A2 shows burst kinetics consistent with the slow, reversible formation of a dead-end complexMatthew G Guenther, Mark R Witmer, James R Burke
Biochemical and Biophysical Research Communications|January 24, 2006
Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondriaKasturi L Puranam, Guanghong Wu, Warren J Strittmatter, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2005
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expressionMark A Pattoli, John F MacMaster, Kurt R Gregor, et al.
Archives of Biochemistry and Biophysics|February 1, 2003
In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's diseaseAlexander V Panov, James R Burke, Warren J Strittmatter, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Current Opinion in Drug Discovery & Development|October 29, 2003
Targeting I kappa B kinase for the treatment of inflammatory and other disordersJames R Burke
Biochemical and Biophysical Research Communications|June 11, 2002
The catalytic subunits of IkappaB kinase, IKK-1 and IKK-2, contain non-equivalent active sites when expressed as homodimersJames R Burke, Joann Strnad
Trends in Pharmacological Sciences|February 9, 2007
IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challengesJoann Strnad, James R Burke
The Journal of Organic Chemistry|January 26, 1996
Correlation of Electronic Effects in N-Alkylnicotinamides with NMR Chemical Shifts and Hydride Transfer ReactivityJames R. Burke, Perry A. Frey
Archives of Physical Medicine and Rehabilitation|January 6, 2012
Sound induced vertigo: superior canal dehiscence resulting from blast exposureAdam Mehlenbacher, Bruce Capehart, Dale Bass, et al.
Methods in Enzymology|October 19, 2006
Phage display screening for peptides that inhibit polyglutamine aggregationDaniel J Kenan, Warren J Strittmatter, James R Burke
Archives of Biochemistry and Biophysics|January 29, 2002
Cytosolic phospholipase A2 shows burst kinetics consistent with the slow, reversible formation of a dead-end complexMatthew G Guenther, Mark R Witmer, James R Burke
Biochemical and Biophysical Research Communications|January 24, 2006
Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondriaKasturi L Puranam, Guanghong Wu, Warren J Strittmatter, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2005
Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expressionMark A Pattoli, John F MacMaster, Kurt R Gregor, et al.
Archives of Biochemistry and Biophysics|February 1, 2003
In vitro effects of polyglutamine tracts on Ca2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's diseaseAlexander V Panov, James R Burke, Warren J Strittmatter, et al.
Pageof 13